Kosan BioSciences -- KOSN Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Kosan BioSciences -- KOSN

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	9/28/2007 6:06:20 PM
	Read Replies (2) of 933

There has been a flurry of Form 4s and amendments - i.e. a couple of them. Reporting share transactions seems to be more complicated than running clinical trials. Anyhow, when the haze has been cut through, it appears as if Johnson (CEO) and Davis (Chairman) has bought 8.000 shares each from the open market. Why they would do such a thing is beyond me - don't they give these guys options? Yes, they have been given such instruments, which are exercisable at or around these share prices. And we are in the case of Johnson talking about more than 100.000 options. So, I don't really see why the guy should even bother to buy shares and risk his money through an open-market purchase. Maybe, they try to tell us something. Like, MLNM is not going to buy us this month, as far as we know. We also had the strange spike in the share price today. Which later collapsed and died - the spike that is, not the share price. It always leaves me wondering when these people start to behave like that. The CEO plus the chairman - at the same time and identical number of shares. Why? Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next